SPEAKERS

Jennifer Doudna
Jennifer Doudna
Nobel Laureate, CRISPR Pioneer, Innovative Genomics Founder
Innovative Genomics Institute
Robert Nelsen
Robert Nelsen
Co-Founder & Managing Director
ARCH Venture Partners
Mark C. McKenna
Mark C. McKenna
Founder, Chairman & CEO
Mirador Therapeutics
Janet Woodcock
Janet Woodcock
Previously
FDA
Stephen Hahn
Stephen Hahn
CEO
Harbinger Health
Johanna DeYoung
Johanna DeYoung
Global Industry Lead, Life Sciences
Slalom
Larry Miller
Larry Miller
CEO
Apnimed, Inc.
Hal Barron
Hal Barron
CEO, Co-Chair & Founder
Altos Labs
Maha Katabi
Maha Katabi
General Partner
Sofinnova Investments
Houman Ashrafian
Houman Ashrafian
EVP, Head of Research & Development
Sanofi
Eric Tokat
Eric Tokat
Co-President
Centerview Partners
Jason C. Foster
Jason C. Foster
CEO
Ori Biotech
Aradhana Sarin
Aradhana Sarin
CFO & Executive Director
AstraZeneca
Sander Slootweg
Sander Slootweg
Managing Partner
Forbion
Marc Tessier-Lavigne
Marc Tessier-Lavigne
CEO
Xaira Therapeutics
Roel van den Akker
Roel van den Akker
Principal, US Pharmaceutical & Life Sciences Deals Leader
PwC US
Mathai Mammen
Mathai Mammen
CEO & Chairman
Parabilis Medicines
Scott Gottlieb
Scott Gottlieb
Partner
New Enterprise Associates
Leo Barella
Leo Barella
SVP & CTO
Takeda Pharmaceuticals Inc.
Jacki Dioguardi
Jacki Dioguardi
Global Pharma CIO, Site Lead, & VP of Informatics
Genentech, a Member of the Roche Group
Marjorie Green
Marjorie Green
SVP, Head of Oncology Clinical Development
Merck
Elina Tetelbaum
Elina Tetelbaum
Corporate Partner
Wachtell, Lipton, Rosen & Katz
Dan Malarek
Dan Malarek
CEO
Foundation Medicine
Julie Rozenblyum
Julie Rozenblyum
SVP, Business Development
Bristol Myers Squibb
Jed Repko
Jed Repko
Partner
Joele Frank
David Reese
David Reese
EVP & Chief Technology Officer
Amgen
Siddhartha Bhattacharya
Siddhartha Bhattacharya
Principal, Pharmaceutical & Life Sciences
PwC
Dina Radenkovic
Dina Radenkovic
Co-Founder & CEO
Gameto
Abe Ceesay
Abe Ceesay
CEO
Rapport Therapeutics
Alessandro Maselli
Alessandro Maselli
President & CEO
Catalent, Inc.
Aharon (Ronny) Gal
Aharon (Ronny) Gal
Chief Strategy & Growth Officer
Novartis
Juliette Cubanski
Juliette Cubanski
Deputy Director, Program on Medicare Policy
KFF
Katherine Andersen
Katherine Andersen
Head of Life Science & Healthcare
HSBC Innovation Banking US
Priya Singhal
Priya Singhal
EVP & Head of Development
Biogen
David Rosewater
David Rosewater
Managing Director, Global Head of Shareholder Activism & Corporate Defense
Morgan Stanley
Stephen J. Ubl
Stephen J. Ubl
President & CEO
PhRMA
Meena Seshamani
Meena Seshamani
Former Deputy Administrator & Director
CMS
Jared Baeten
Jared Baeten
SVP, Clinical Development, Virology Therapeutic Area Head
Gilead Sciences
Patrick Loerch
Patrick Loerch
SVP, Clinical Data Science
Gilead Sciences

MODERATORS

Andrew Dunn
Andrew Dunn
Biopharma Correspondent
Endpoints News
Arsalan Arif
Arsalan Arif
Founder & Publisher
Endpoints News
Drew Armstrong
Drew Armstrong
Executive Editor
Endpoints News
John Carroll
John Carroll
Founder & Editor
Endpoints News
Kyrsten Musich
Kyrsten Musich
Head of Healthcare & Life Sciences Industry Team
Salesforce
Lei Lei Wu
Lei Lei Wu
News Reporter
Endpoints News
Kyle LaHucik
Kyle LaHucik
Senior Reporter
Endpoints News
Max Bayer
Max Bayer
Pharma Reporter
Endpoints News
Jaimy Lee
Jaimy Lee
Deputy Editor, Newsletters
Endpoints News